Bioject Medical Technologies In
(BJCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,589 | -9,081 | -9,332 | N/A | -8,491 |
| Depreciation Amortization | 1,166 | 852 | 533 | N/A | 398 |
| Accounts receivable | -1,359 | 269 | -738 | N/A | -1,227 |
| Accounts payable and accrued liabilities | -24 | 144 | 630 | N/A | 291 |
| Other Working Capital | 857 | -440 | 688 | N/A | -1,696 |
| Other Operating Activity | 2,202 | -71 | 393 | 0 | 4,064 |
| Operating Cash Flow | $-3,748 | $-8,326 | $-7,826 | $N/A | $-6,661 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,326 | 5,521 | 4,135 | N/A | -10,542 |
| PPE Investments | -1,211 | -1,328 | -2,237 | N/A | -2,045 |
| Other Investing Activity | -192 | 1,275 | -1,763 | 0 | -127 |
| Investing Cash Flow | $923 | $5,468 | $135 | $N/A | $-12,714 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 961 | -1,500 | 1,500 | N/A | N/A |
| Debt Issued | N/A | 3,000 | N/A | N/A | N/A |
| Debt Repayment | -1,050 | -37 | -22 | N/A | -10 |
| Common Stock Issued | 111 | 173 | 210 | N/A | 20,744 |
| Other Financing Activity | 0 | 2,178 | 0 | 0 | 0 |
| Financing Cash Flow | $21 | $3,814 | $1,688 | $N/A | $20,733 |
| Beginning Cash Position | 3,849 | 2,894 | 8,896 | N/A | 6,255 |
| End Cash Position | 1,045 | 3,849 | 2,894 | N/A | 7,613 |
| Net Cash Flow | $-2,803 | $955 | $-6,002 | $N/A | $1,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,748 | -8,326 | -7,826 | N/A | -6,661 |
| Capital Expenditure | -1,211 | -1,328 | -2,237 | N/A | -2,554 |
| Free Cash Flow | -4,958 | -9,654 | -10,063 | 0 | -9,215 |